Family Medicine · Elyria, OH
NPI
1952513277
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1120 E Broad St
Elyria, OH, 44035
Phone (440) 365-2600
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
1,200 services
Medicare patients, 2024
237
Average age 74
Drug cost, 2024
$824K
9,902 prescriptions
Company payments, 2025
$1,970
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas J Ksenich was code 99214 (office e&m - established), 633 times for 227 patients. In total Nicholas J Ksenich billed 1,200 services in 26 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 633 | 227 | $34.90 | $22K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 182 | 182 | $49.38 | $8,986 |
| G0008 Administration of influenza virus vaccine | Office | 46 | 46 | $30.40 | $1,398 |
| 90662 Vaccine Product | Office | 45 | 45 | $65.66 | $2,955 |
| 96372 Injection Administration | Office | 39 | 13 | $9.42 | $367 |
| G0009 Administration of pneumococcal vaccine | Office | 25 | 25 | $30.57 | $764 |
| 90677 Vaccine Product | Office | 25 | 25 | $286.93 | $7,173 |
| 99215 Office E&M - Established | Office | 20 | 16 | $39.06 | $781 |
| 99213 Office E&M - Established | Office | 15 | 15 | $48.49 | $727 |
| 99443 Telephone Services | Office | 14 | 12 | $76.99 | $1,078 |
By year: 2022 $46K for 1,399 services; 2023 $51K for 1,361 services; 2024 $49K for 1,200 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 14 | 11 | $9.60 | $134 |
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas J Ksenich prescribed most often to Medicare patients was Atorvastatin Calcium, with 555 prescriptions and refills. In total Nicholas J Ksenich wrote 9,902 Medicare prescriptions that cost $824K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 555 | 1,553 | 178 | $5,648 |
| Levothyroxine Sodium Generic | 502 | 1,125 | 119 | $4,540 |
| Lisinopril Generic | 460 | 1,191 | 129 | $1,888 |
| Amlodipine Besylate Generic | 309 | 790 | 90 | $1,538 |
| Pantoprazole Sodium Generic | 272 | 625 | 93 | $3,157 |
| Gabapentin Generic | 270 | 422 | 73 | $3,622 |
| Metformin Hcl Generic | 212 | 563 | 59 | $1,395 |
| Citalopram Hbr Citalopram Hydrobromide | 212 | 432 | 47 | $1,196 |
| Losartan Potassium Generic | 209 | 540 | 62 | $2,479 |
| Simvastatin Generic | 186 | 504 | 51 | $1,944 |
| Omeprazole Generic | 175 | 430 | 48 | $1,937 |
| Metoprolol Tartrate Generic | 153 | 346 | 41 | $726 |
| Tamsulosin Hcl Generic | 150 | 341 | 47 | $1,922 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 144 | 169 | 48 | $3,356 |
| Cyclobenzaprine Hcl Generic | 133 | 171 | 45 | $1,280 |
Brand drugs: 1,039 claims; generic drugs: 8,797 claims; opioid claims: 184.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas J Ksenich $1,970 ($1,970 in general payments such as food, travel and fees) from 26 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $299.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 15 | $299 |
| Novo Nordisk Inc NVO | 9 | $156 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $148 |
| Lilly USA, LLC LLY | 9 | $143 |
| GlaxoSmithKline, LLC. GSK | 9 | $142 |
| Abbvie Inc. ABBV | 6 | $118 |
| Xeris Pharmaceuticals, Inc. | 5 | $116 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $112 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $73.57 |
| Pfizer Inc. PFE | 4 | $61.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.